LITERATURE REVIEW OF ECONOMIC AND CLINICAL OUTCOMES ASSOCIATED WITH MULTIPLE DAILY INSULIN INJECTION (MDI) THERAPY FOR PATIENTS WITH TYPE 2 DIABETES MELLITUS (T2DM)

被引:0
|
作者
Mathur, I [1 ]
Trenery, A. [2 ]
Simon, A. [1 ]
Gala, S. [1 ]
Ermakova, A. [1 ]
Weiss, M. [1 ]
Taylor, S. [1 ]
机构
[1] Becton Dickinson & Co, Franklin Lakes, NJ USA
[2] Becton Dickinson & Co, Montclair, NJ USA
关键词
D O I
10.1016/j.jval.2019.04.601
中图分类号
F [经济];
学科分类号
02 ;
摘要
PDB52
引用
收藏
页码:S149 / S149
页数:1
相关论文
共 50 条
  • [21] TYPE 2 DIABETES MELLITUS (T2DM) IN PATIENTS WITH HIP FRACTURE (HF): PREVALENCE, COMORBIDITIES, AND OUTCOMES
    Chavalertsakul, Nuttaya
    Srikusalanukul, Wichat
    Fisher, Alexander
    [J]. INTERNAL MEDICINE JOURNAL, 2022, 52 : 11 - 11
  • [22] Efficacy and safety of insulin glargine added to ongoing therapy with multiple oral antidiabetic drugs (OADs) in patients with type 2 diabetes mellitus (T2DM)
    Raskin, P.
    Tanenberg, R. J.
    Vlajnic, A.
    Hollander, P.
    [J]. DIABETOLOGIA, 2007, 50 : S405 - S406
  • [23] Glycaemic control and pregnancy outcomes in women with Type 2 diabetes mellitus (T2DM)
    Pang, W. H.
    Tan, Z.
    Todd, D.
    Halliday, M.
    Gill, F.
    Rhoads, M.
    Sathiskumar, P.
    Gallagher, A.
    de Chazal, R.
    Lawrence, I. G.
    [J]. DIABETIC MEDICINE, 2008, 25
  • [24] Pharmacogenomics and pharmacomicrobiomics in type 2 diabetes mellitus (T2DM)
    Luo, Jian-Quan
    Shu, Yan
    Zhang, Wei
    [J]. FRONTIERS IN ENDOCRINOLOGY, 2023, 14
  • [25] Vascular responsiveness in type 2 diabetes mellitus (T2DM)
    Blum, A.
    Socea, D.
    Sirchan, R.
    [J]. QJM-AN INTERNATIONAL JOURNAL OF MEDICINE, 2016, 109 (12) : 791 - 796
  • [26] The platelets characteristics in type 2 diabetes mellitus (T2DM)
    Buryachkovskaya, L.
    Uchitel, I. A.
    Sumarokov, A. B.
    Docenko, U., V
    [J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2015, 13 : 931 - 931
  • [27] Microvascular complications in type 2 diabetes mellitus (T2DM).
    Cheung, AT
    Ramanujam, S
    Duong, PL
    Schauer, D
    Chan, LS
    Dwyre, DM
    Larkin, EC
    [J]. FASEB JOURNAL, 2002, 16 (04): : A208 - A208
  • [28] Efficacy and safety of insulin glargine added to ongoing therapy with multiple oral antidiabetic drugs (OADs) in patients with type 2 diabetes mellitus (T2DM)
    Davidson, Mayer B.
    Raskin, Philip
    Tanenberg, Robert
    Vlajnic, Aleksandra
    Hollander, Priscilla
    [J]. DIABETES, 2007, 56 : A542 - A542
  • [29] Impact of Endocrine Care on Glycemic Management in Type 2 Diabetes (T2DM) Using either Continuous Subcutaneous Insulin Infusion (CSII) or Multiple Daily Insulin Injections (MDI)
    Manroa, Pooja
    Potoski, Laura
    Martin, Emily
    Rao, R. Harsha
    [J]. DIABETES, 2016, 65 : A255 - A255
  • [30] Stepwise Intensification of Prandial Insulin Versus Basal-Bolus Insulin Therapy in Patients (Pts) with Type 2 Diabetes Mellitus (T2DM)
    Raccah, Denis
    Haak, Thomas
    Huet, Dominique
    Monnier, Louis
    Penfornis, Alfred
    Robertson, Douglas
    Labard, Pascale
    Soler Ramon, Juan
    [J]. DIABETES, 2010, 59 : A151 - A151